医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

JMJD6 protects against isoproterenol-induced cardiac hypertrophy via inhibition of NF-κB activation by demethylating R149 of the p65 subunit

广告
作者单位 School of Pharmaceutical Sciences,Shandong First Medical University & Shandong Academy of Medical Sciences,Taian 271016,China;Department of Pharmacology and Toxicology,School of Pharmaceutical Sciences;National and Local United Engineering Lab of Druggability and New Drugs Evaluation;Guangdong Engineering Laboratory of Druggability and New Drug Evaluation;Guangdong Provincial Key Laboratory of New Drug Design and Evaluation,Sun Yat-sen University,Guangzhou 510006,China;Center for Cardiovascular Research,Cardiovascular Division,Department of Medicine,Washington University School of Medicine,St.Louis,MO 63110,USA [1] Department of Pharmacology and Toxicology,School of Pharmaceutical Sciences;National and Local United Engineering Lab of Druggability and New Drugs Evaluation;Guangdong Engineering Laboratory of Druggability and New Drug Evaluation;Guangdong Provincial Key Laboratory of New Drug Design and Evaluation,Sun Yat-sen University,Guangzhou 510006,China [2] Department of Pharmacology and Toxicology,School of Pharmaceutical Sciences;National and Local United Engineering Lab of Druggability and New Drugs Evaluation;Guangdong Engineering Laboratory of Druggability and New Drug Evaluation;Guangdong Provincial Key Laboratory of New Drug Design and Evaluation,Sun Yat-sen University,Guangzhou 510006,China;Center for Cardiovascular Research,Cardiovascular Division,Department of Medicine,Washington University School of Medicine,St.Louis,MO 63110,USA [3] Center for Cardiovascular Research,Cardiovascular Division,Department of Medicine,Washington University School of Medicine,St.Louis,MO 63110,USA [4] Department of Cardiac Surgery,First Affiliated Hospital,Sun Yat-sen University,Guangzhou 510080,China [5] School of Pharmaceutical Sciences,Shandong First Medical University & Shandong Academy of Medical Sciences,Taian 271016,China [6] School of Pharmaceutical Sciences,Shandong First Medical University & Shandong Academy of Medical Sciences,Taian 271016,China;Department of Pharmacology and Toxicology,School of Pharmaceutical Sciences;National and Local United Engineering Lab of Druggability and New Drugs Evaluation;Guangdong Engineering Laboratory of Druggability and New Drug Evaluation;Guangdong Provincial Key Laboratory of New Drug Design and Evaluation,Sun Yat-sen University,Guangzhou 510006,China [7]
DOI 10.1038/s41401-023-01086-7
发布时间 2023-10-07(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览0
  • 下载0
中国药理学报(英文版)

中国药理学报(英文版)

2023年44卷9期

1777-1789页

SCIMEDLINEISTICCSCDCABP

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷